Heterogeneous and dynamic prevalence of asymptomatic influenza virus infections

Emerging Infectious Diseases

Volumn 22, Issue 6, 2016, Pages 1052-1056

  Furuya Kanamori, Luis ^a   Cox, Mitchell ^b   Milinovich, Gabriel J ^b   Soares Magalhaes, Ricardo J ^b   Mackay, Ian M ^c   Yakob, Laith ^d  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASYMPTOMATIC DISEASE; DISEASE CONTROL; INFLUENZA; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H1N1); META ANALYSIS; NONHUMAN; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SYSTEMATIC REVIEW; VIRUS CULTURE; VIRUS TRANSMISSION; ASYMPTOMATIC INFECTION; HEALTH SURVEY; HUMAN; PUBLISHING; VIROLOGY;

ASYMPTOMATIC INFECTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; POPULATION SURVEILLANCE; PREVALENCE; PUBLICATION BIAS;

EID: 84969220016     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2206.151080     Document Type: Article

References (23)

1. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008;3:499-522. http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.154316
2. Cox NJ, Subbarao K. Influenza. Lancet. 1999;354:1277-1282. http://dx.doi.org/10.1016/S0140-6736(99)01241-6
3. Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng P-Y, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12:687-695. http://dx.doi.org/10.1016/S1473-3099(12)70121-4
4. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128. http://dx.doi.org/10.1016/S0140-6736(12)61728-0
5. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380:2197-2223. http://dx.doi.org/10.1016/S0140-6736(12)61689-4
6. Elder AG, O’Donnell B, McCruden EA, Symington IS, Carman WF. Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire. BMJ. 1996;313:1241-1242. http://dx.doi.org/10.1136/bmj.313.7067.1241
7. Mathews JD, McCaw CT, McVernon J, McBryde ES, McCaw JM. A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity. PLoS One. 2007;2:e1220. http://dx.doi.org/10.1371/journal.pone.0001220
8. Halloran ME, Hayden FG, Yang Y, Longini IM Jr., Monto AS. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol. 2007; 165:212-221. http://dx.doi.org/10.1093/aje/kwj362
9. Arden KE, Mackay IM. Avian influenza A (H7N9) virus: can it help us more objectively judge all respiratory viruses? J Clin Virol. 2013;58:338-339. http://dx.doi.org/10.1016/j.jcv.2013.05.015
10. Le MQ, Horby P, Fox A, Nguyen HT, Le Nguyen HK, Hoang PM, et al. Subclinical avian influenza A(H5N1) virus infection in human, Vietnam. Emerg Infect Dis. 2013;19:1674-1677. http://dx.doi.org/10.3201/eid1910.130730
11. Lo YC, Chen WC, Huang WT, Lin YC, Liu MC, Kuo HW, et al. Surveillance of avian influenza A(H7N9) virus infection in humans and detection of the first imported human case in Taiwan, 3 April to 10 May 2013. Euro Surveill. 2013;18:20479.
12. Song R, Pang X, Yang P, Shu Y, Zhang Y, Wang Q, et al. Surveillance of the first case of human avian influenza A (H7N9) virus in Beijing, China. Infection. 2014;42:127-133. http://dx.doi.org/10.1007/s15010-013-0533-9
13. Van Kerckhove K, Hens N, Edmunds WJ, Eames KTD. The impact of illness on social networks: implications for transmission and control of influenza. Am J Epidemiol. 2013;178:1655-1662. http://dx.doi.org/10.1093/aje/kwt196
14. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:775-785. http://dx.doi.org/10.1093/aje/kwm375
15. Longini IM Jr., Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. Am J Epidemiol. 2004;159:623-633. http://dx.doi.org/10.1093/aje/kwh092
16. Germann TC, Kadau K, Longini IM Jr., Macken CA. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci U S A. 2006;103:5935-5940. http://dx.doi.org/10.1073/pnas.0601266103
17. Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature. 2006;442:448-452. http://dx.doi.org/10.1038/nature04795
18. Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12:15-22. http://dx.doi.org/10.3201/eid1209.05-0979
19. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. http://dx.doi.org/10.1371/journal.pmed.1000097
20. World Health Organization. WHO Global Epidemiological Surveillance Standards for Influenza. 2014 [cited January 2015]. http://www.who.int/entity/influenza/resources/documents/WHO_ Epidemiological_Influenza_Surveillance:Standards_2014.pdf?ua=1
21. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65:934-939. http://dx.doi.org/10.1016/j.jclinepi.2011.11.014
22. Doi SA, Barendregt JJ, Khan S, Thalib L, Williams GM. Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model. Contemp Clin Trials. 2015;45(Pt A):130-138. http://dx.doi.org/10.1016/j.cct.2015.05.009
23. Lambert SB, Faux CE, Grant KA, Williams SH, Bletchly C, Catton MG, et al. Influenza surveillance in Australia: we need to do more than count. Med J Aust. 2010;193:43-45.